Zonova

Zonova, an antimicrobial materials company focused on developing next-generation infection-resistant medical devices, has successfully secured £2.1 million in a Seed funding round led by THENA Capital.

Summary of transaction details:

• Value: £2.1 million
• Sector: Healthcare & Biotech
• Advisor: Not specified
• Key Entities: Zonova (Target), THENA Capital (Lead Investor)
• Location: London, UK

Note: This Seed investment will enable Zonova to advance its pioneering work in antimicrobial materials, crucial for developing medical devices that combat infections and enhance patient safety within the healthcare sector.